Search

everythinglearnresearchcommunity

for

Search:↓

Breezula® may be more effective than Minoxidil in promoting hair growth by reducing a hair growth inhibitor.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Total glucosides of paeony may help treat alopecia areata by reducing inflammation and hair loss.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Combining low-level light therapy and minoxidil 5% is more effective for female hair loss than using either treatment alone.

The model helps test drugs for clubfoot fibrosis by mimicking cell environments and shows minoxidil reduces harmful collagen links.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

The diphosphonate was the most effective at preventing calcification in rats.

miR-325-3p can slow down brain tumor growth by targeting FOXM1.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Modulating the BTNL2 pathway can prevent hair loss in mice.

Six existing drugs may help block virus entry in COVID-19.

Oral minoxidil can increase or maintain hair thickness in most people with lichen planopilaris, with mild side effects.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

These new skin treatments are safer and more effective with minimal side effects.